BioSpace News Archive

NeoImmuneTech, Inc., announced that Luke Oh, Ph.D. has been appointed as President and Chief Executive Officer of NeoImmuneTech, Inc., effective from March 29, 2024.

Verrica Pharmaceuticals Inc. announced that Ted White, Verrica’s President & Chief Executive Officer, will present at the upcoming 23rd Annual Needham Virtual Healthcare Conference, which is being held virtually from April 8-11, 2024.

Arthrex, a global leader in minimally invasive surgical technology, announced the 10th anniversary of the InternalBrace™ ligament augmentation system.

Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the 23rd Annual Needham Virtual Healthcare Conference at 8:00 AM ET on Monday, April 8, 2024.

MaxCyte, Inc. and Be Biopharma announced the signing of a strategic platform license to support the development of Be Bio’s BCMs programs.

Anika Therapeutics, Inc. today announced that management will participate in the 23rd Annual Needham Virtual Healthcare Conference on Monday, April 8, 2024.

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a precision oncology company with a diversified portfolio, announced today the first patient in the U.S. has been dosed in the Phase 1 clinical trial of CRB-701 (SYS6002), a next-generation antibody-drug-conjugate (ADC) targeting Nectin-4.

Spectral Medical Inc. announced that Anthony Bihl III, Spectral’s Chairman, will be retiring from the Board at Spectral’s upcoming Shareholder Meeting in June 2024.

Bionano Genomics, Inc. announced its participation in the American Association for Cancer Research Annual Meeting 2024 with a broad range of content covering the utility of OGM for cell bioprocessing quality control, solid tumor and hematological malignancy cancer research.

MIRA Pharmaceuticals, Inc. today shares updates on the ongoing pre-clinical studies of its investigational compound, Ketamir-2, a novel oral ketamine analog which could potentially deliver ultra-rapid antidepressant effects.